SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-028277
Filing Date
2023-10-16
Accepted
2023-10-16 16:00:20
Documents
2
Period of Report
2023-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 8063
2 atos_ex24.htm EX-24 7459
  Complete submission text file 0001437749-23-028277.txt   16943
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104
Business Address
Rees Heather (Reporting) CIK: 0001997454 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35610 | Film No.: 231327342